Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | KU004 |
Synonyms | |
Therapy Description |
KU004 is a quinazoline derivative with structural similarity to lapatinib inhibiting both Egfr and Erbb2 (Her2) in vitro (PMID: 26437915, PMID: 28532652). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
KU004 | EGFR Inhibitor (Pan) 61 HER2 Inhibitor 41 | KU004 is a quinazoline derivative with structural similarity to lapatinib inhibiting both Egfr and Erbb2 (Her2) in vitro (PMID: 26437915, PMID: 28532652). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|